Improved Efficiency and Pace of Generating Induced Pluripotent Stem Cells from Human Adult and Fetal Fibroblasts
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
It was reported recently that human fibroblasts can be reprogrammed into a pluripotent state that resembles that of human embryonic stem (hES) cells. This was achieved by ectopic expression of four genes followed by culture on mouse embryonic fibroblast (MEF) feeders under a condition favoring hES cell growth. However, the efficiency of generating human induced pluripotent stem (iPS) cells is low, especially for postnatal human fibroblasts. We started supplementing with an additional gene or bioactive molecules to increase the efficiency of generating iPS cells from human adult as well as fetal fibroblasts. We report here that adding SV40 large T antigen (T) to either set of the four reprogramming genes previously used enhanced the efficiency by 23–70-fold from both human adult and fetal fibroblasts. Discernible hES-like colonies also emerged 1–2 weeks earlier if T was added. With the improved efficiency, we succeeded in replacing MEFs with immortalized human feeder cells that we previously established for optimal hES cell growth. We further characterized individually picked hES-like colonies after expansion (up to 24 passages). The majority of them expressed various undifferentiated hES markers. Some but not all the hES-like clones can be induced to differentiate into the derivatives of the three embryonic germ layers in both teratoma formation and embryoid body (EB) formation assays. These pluripotent clones also differentiated into trophoblasts after EB formation or bone morphogenetic protein 4 induction as classic hES cells. Using this improved approach, we also generated hES-like cells from homozygous fibroblasts containing the sickle cell anemia mutation Hemoglobin Sickle. Disclosure of potential conflicts of interest is found at the end of this article.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“More studies are working on enhancing the iPSC reprogramming efficiency, such as by adding SV40 large T antigen (T) by 23–70-fold from human fibroblasts [104].”
From Non-Integrating Lentiviral Vectors in Clinical Applications: A Glance Through (2022) · cites this paper as [104]
In the citing paper
“Suppression of p53 by viral protein or siRNA facilitated reprograming of iPS [70, 71].”
From Ultraviolet Radiation‐Induced Skin Aging: The Role of DNA Damage and Oxidative Stress in Epidermal Stem Cell Damage Mediated Skin Aging (2016) · cites this paper as [71]
Citations
Cites
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310
Reprogramming of human somatic cells to pluripotency with defined factors
Park, I.-H., Zhao, R., West, J. A., Yabuuchi, A., Huo, H., Ince, T. A., Lerou, P. H., Lensch, M. W., & Daley, G. Q. (2008) · Nature · doi:10.1038/nature06534 · Cited by 2,436
Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts
Nakagawa, M., Koyanagi, M., Tanabe, K., Takahashi, K., Ichisaka, T., Aoi, T., Okita, K., Mochiduki, Y., Takizawa, N., & Yamanaka, S. (2008) · Nature Biotechnology · doi:10.1038/nbt1374 · Cited by 2,380
Creation of human tumour cells with defined genetic elements
Hahn, W. C., Counter, C. M., Lundberg, A. S., Beijersbergen, R. L., Brooks, M. W., & Weinberg, R. A. (1999) · Nature · doi:10.1038/22780 · Cited by 2,345
Generation of human induced pluripotent stem cells from dermal fibroblasts
Lowry, W. E., Richter, L., Yachechko, R., Pyle, A. D., Tchieu, J., Sridharan, R., Clark, A. T., & Plath, K. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711983105 · Cited by 1,041
Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells
Draper, J. S., Smith, K., Gokhale, P., Moore, H. D., Maltby, E., Johnson, J., Meisner, L., Zwaka, T. P., Thomson, J. A., & Andrews, P. W. (2004) · Nature Biotechnology · doi:10.1038/nbt922 · Cited by 1,021
c-Myc Is Dispensable for Direct Reprogramming of Mouse Fibroblasts
Wernig, M., Meissner, A., Cassady, J. P., & Jaenisch, R. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2007.12.001 · Cited by 628
Enumeration of the Simian Virus 40 Early Region Elements Necessary for Human Cell Transformation
Hahn, W. C., Dessain, S. K., Brooks, M. W., King, J. E., Elenbaas, B., Sabatini, D. M., DeCaprio, J. A., & Weinberg, R. A. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.7.2111-2123.2002 · Cited by 612
SV40 large T antigen targets multiple cellular pathways to elicit cellular transformation
Ahuja, D., Sáenz-Robles, M. T., & Pipas, J. M. (2005) · Oncogene · doi:10.1038/sj.onc.1209046 · Cited by 557
Cited by
The tumorigenicity of human embryonic and induced pluripotent stem cells
Ben-David, U., & Benvenisty, N. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3034 · Cited by 889
“In agreement, some reprogrammed lines fail to differentiate and form undifferentiated tumours on injection into immunodeficient mic”
BackgroundImmortalization eliminates a roadblock during cellular reprogramming into iPS cells
Utikal, J., Polo, J. M., Stadtfeld, M., Maherali, N., Kulalert, W., Walsh, R. M., Khalil, A., Rheinwald, J. G., & Hochedlinger, K. (2009) · Nature · doi:10.1038/nature08285 · Cited by 836
Induced pluripotency: history, mechanisms, and applications
Stadtfeld, M., & Hochedlinger, K. (2010) · Genes & Development · doi:10.1101/gad.1963910 · Cited by 829
“For instance, overexpression of SV40 large T antigen (Mali et al. 2008; Park et al. 2008c) or Rem2 GTPase (Edel et al.”
BackgroundOkita, K., Yamakawa, T., Matsumura, Y., Sato, Y., Amano, N., Watanabe, A., Goshima, N., & Yamanaka, S. (2013) · Stem Cells · doi:10.1002/stem.1293 · Cited by 749
Gene Targeting of a Disease-Related Gene in Human Induced Pluripotent Stem and Embryonic Stem Cells
Zou, J., Maeder, M. L., Mali, P., Pruett-Miller, S. M., Thibodeau-Beganny, S., Chou, B.-K., Chen, G., Ye, Z., Park, I.-H., Daley, G. Q., et al. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.05.023 · Cited by 509
Self-citationChou, B.-K., Mali, P., Huang, X., Ye, Z., Dowey, S. N., Resar, L. M., Zou, C., Zhang, Y. A., Tong, J., & Cheng, L. (2011) · Cell Research · doi:10.1038/cr.2011.12 · Cited by 484
Self-citationTwo Supporting Factors Greatly Improve the Efficiency of Human iPSC Generation
Zhao, Y., Yin, X., Qin, H., Zhu, F., Liu, H., Yang, W., Zhang, Q., Xiang, C., Hou, P., Song, Z., et al. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.10.002 · Cited by 468
Singh, V. K., Kalsan, M., Kumar, N., Saini, A., & Chandra, R. (2015) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2015.00002 · Cited by 416
“…factors or to enhance the efficiency of reprogramming (Table 1) (Yu et al., 2007; Dimos et al., 2008; Hanna et al., 2008; Huangfu et al., 2008a,b; Mali et al., 2008; Marson et al., 2008; Mikkelsen et al., 2008; Park et al., 2008a; Shi et al., 2008a,b; Silva et al., 2008; Zhao et al., 2008; Zhou…”
BackgroundGeneration of Induced Pluripotent Stem Cell Lines from Tibetan Miniature Pig
Esteban, M. A., Xu, J., Yang, J., Peng, M., Qin, D., Li, W., Jiang, Z., Chen, J., Deng, K., Zhong, M., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.008938 · Cited by 418
Mali, P., Chou, B.-K., Yen, J., Ye, Z., Zou, J., Dowey, S., Brodsky, R. A., Ohm, J. E., Yu, W., Baylin, S. B., et al. (2010) · Stem Cells · doi:10.1002/stem.402 · Cited by 417
Self-citationYe, Z., Zhan, H., Mali, P., Dowey, S., Williams, D. M., Jang, Y.-Y., Dang, C. V., Spivak, J. L., Moliterno, A. R., & Cheng, L. (2009) · Blood · doi:10.1182/blood-2009-04-217406 · Cited by 399
“They are cultured on pre-seeded embryonic fibroblast (MEF) feeder cells for programming similar to what we previously described.(4) At day 7, the hES cell medium was used and throughout.”
MethodSelf-citationMolecules that Promote or Enhance Reprogramming of Somatic Cells to Induced Pluripotent Stem Cells
Feng, B., Ng, J.-H., Heng, J.-C. D., & Ng, H.-H. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.03.005 · Cited by 381
Panich, U., Sittithumcharee, G., Rathviboon, N., & Jirawatnotai, S. (2016) · Stem Cells International · doi:10.1155/2016/7370642 · Cited by 374
“Suppression of p53 by viral protein or siRNA facilitated repro-graming of iPS [70, 71].”
Generation of Insulin-secreting Islet-like Clusters from Human Skin Fibroblasts
Tateishi, K., He, J., Taranova, O., Liang, G., D'Alessio, A. C., & Zhang, Y. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m806597200 · Cited by 358
Yu, J., & Thomson, J. A. (2008) · Genes & Development · doi:10.1101/gad.1689808 · Cited by 342
“Inclusion of additional factors, such as TERT, T genes, and down-regulation of somatic cellspecific transcription factors (e.g., down-regulation of Pax5 in mature B cells), can improve the reprogramming efficiency (Hanna et al. 2008; Mali et al. 2008).”
BackgroundReprogramming cell fates: reconciling rarity with robustness
Huang, S. (2009) · BioEssays · doi:10.1002/bies.200800189 · Cited by 320
“Yet, the actual event of reprogramming at the level of individual cells is in general rare, occurring at a frequency of <1%.((24,25)) Thus, one challenge for a theory will be to explain how a complicated, intuitively unlikely and rare biological event is inherently robust, that is, given appropriate conditions, almost…”
BackgroundZou, J., Mali, P., Huang, X., Dowey, S. N., & Cheng, L. (2011) · Blood · doi:10.1182/blood-2011-02-335554 · Cited by 295
Self-citationPapapetrou, E. P., Tomishima, M. J., Chambers, S. M., Mica, Y., Reed, E., Menon, J., Tabar, V., Mo, Q., Studer, L., & Sadelain, M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904825106 · Cited by 286
“Furthermore, the system presented herein can be used for packaging of integrase-deficient lentiviral vectors to facilitate tracking of transient reprogramming factor expression and screening of clones devoid of integrated vectors (8, 9, 34).”
MethodThe promises and perils of p53
Krizhanovsky, V., & Lowe, S. W. (2009) · Nature · doi:10.1038/4601085a · Cited by 274
Efficient Feeder-Free Episomal Reprogramming with Small Molecules
Yu, J., Chau, K. F., Vodyanik, M. A., Jiang, J., & Jiang, Y. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017557 · Cited by 254
“A second report showed that the SV40LT expression enhanced both the reprogramming efficiency and the reprogramming pace [34].”
BackgroundIntegration-deficient Lentiviral Vectors: A Slow Coming of Age
Wanisch, K., & Yáñez-Muñoz, R. J. (2009) · Molecular Therapy · doi:10.1038/mt.2009.122 · Cited by 222
“22 (96) HIV-1 D64V SIN 1 Yes hEF1α OCT4, SOX2, NANOG, LIN28, SV40 large T-antigen VSV-G p24 ELISA”
Type V Collagen in Scar Tissue Regulates the Size of Scar after Heart Injury
Yokota, T., McCourt, J., Ma, F., Ren, S., Li, S., Kim, T.-H., Kurmangaliyev, Y. Z., Nasiri, R., Ahadian, S., Nguyen, T., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.030 · Cited by 209
“To minimize artifacts from repeated passaging, we immortalized the isolated Col5a1fl/fl cardiac fibroblasts by infecting them with a lentivirus encoding the SV40 large T cell antigen prior to infecting the cells with Cre recombinase or control GFP virus (Mali et al., 2008; Welm et al., 2008).”
Omole, A. E., & Fakoya, A. O. J. (2018) · PeerJ · doi:10.7717/peerj.4370 · Cited by 204
“Conversely, overexpression of p53 inhibitor proteins (such as SV40 large T antigen, REM2, and MDM2), increased the efficiency of reprogramming (up to 23-fold compared to OSKM alone) (Park et al., 2008a; Hong et al., 2009; Mali et al., 2008; Edel et al., 2010).”
BackgroundStem Cell Therapy for Vascular Regeneration: Adult, Embryonic, and Induced Pluripotent Stem Cells
Leeper, N. J., Hunter, A. L., & Cooke, J. P. (2010) · Circulation · doi:10.1161/circulationaha.109.881441 · Cited by 195
Reprogramming Cellular Identity for Regenerative Medicine
Cherry, A. B. C., & Daley, G. Q. (2012) · Cell · doi:10.1016/j.cell.2012.02.031 · Cited by 191
Dowey, S. N., Huang, X., Chou, B.-K., Ye, Z., & Cheng, L. (2012) · Nature Protocols · doi:10.1038/nprot.2012.121 · Cited by 174
Self-citationHotta, A., & Ellis, J. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21912 · Cited by 173
“, 2007], and additional genes such as TERT and SV40 large T may facilitate the process [Mali et al., 2008; Park et al., 2008].”
BackgroundRizzino, A. (2009) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.12 · Cited by 166
Christova, Y., Adrain, C., Bambrough, P., Ibrahim, A., & Freeman, M. (2013) · EMBO reports · doi:10.1038/embor.2013.128 · Cited by 145
“All MEFs were immortalized using lentiviral transduction of SV40 virus large T antigen (Ef1a_Large T-antigen_Ires_Puro, Addgene plasmid 18922 [25]).”
Bao, L., He, L., Chen, J., Wu, Z., Liao, J., Rao, L., Ren, J., Li, H., Zhu, H., Qian, L., et al. (2011) · Cell Research · doi:10.1038/cr.2011.6 · Cited by 139
Germline duplication of ATG2B and GSKIP predisposes to familial myeloid malignancies
Saliba, J., Saint‐Martin, C., Stefano, A. D., Lenglet, G., Marty, C., Keren, B., Pasquier, F., Della-Valle, V., Secardin, L., Leroy, G., et al. (2015) · Nature Genetics · doi:10.1038/ng.3380 · Cited by 150
Embryonic stem cell-like cells derived from adult human testis
Mizrak, S. C., Chikhovskaya, J. V., Sadri‐Ardekani, H., van Daalen, S. K. M., Korver, C. M., Hovingh, S., Roepers‐Gajadien, H. L., Raya, Á., Fluiter, K., de Reijke, T. M., et al. (2009) · Human Reproduction · doi:10.1093/humrep/dep354 · Cited by 131
“Recently, induced pluripotent stem cells (iPS cells) have successfully been derived from adult and fetal human fibroblasts (Takahashi et al., 2007; Lowry et al., 2008; Mali et al., 2008; Nakagawa et al., 2008; Park et al., 2008).”
BackgroundMaeda, T., Nagano, S., Ichise, H., Kataoka, K., Yamada, D., Ogawa, S., Koseki, H., Kitawaki, T., Kadowaki, N., Takaori-Kondo, A., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-1149 · Cited by 123
Technological Overview of iPS Induction from Human Adult Somatic Cells
Bayart, E., & Cohen-Haguenauer, O. (2013) · Current Gene Therapy · doi:10.2174/1566523211313020002 · Cited by 113
“Since Yamanaka’s group reported the generation of mouse and human iPS cells via retroviral-mediated ectopic expression of OCT4 (also known as POU5F1), SOX2, KLF4 and c-MYC (so called OSKM cocktail) [5, 104], this canonical cocktail now has proved efficient on a wide range of human cell types with integrative delivery…”
InfluentialSuicide Gene Therapy for Cancer; Old Dog New Tricks
Zarogoulidis, P. (2013) · Journal of Genetic Syndromes & Gene Therapy · doi:10.4172/2157-7412.1000139 · Cited by 125
Cai, L., Bai, H., Mahairaki, V., Gao, Y., He, C., Wen, Y., Jin, Y.-C., Wang, Y., Pan, R. L., Qasba, A., et al. (2017) · Stem Cells Translational Medicine · doi:10.1002/sctm.17-0066 · Cited by 111
Self-citationAustad, S. N. (2009) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/gln060 · Cited by 104
Amniotic Fluid Cells Are More Efficiently Reprogrammed to Pluripotency Than Adult Cells
Galende, E., Karakikes, I., Edelmann, L., Desnick, R. J., Kerenyi, T., Khoueiry, G., Lafferty, J., McGinn, J. T., Brodman, M., Fuster, V., et al. (2010) · Cellular Reprogramming · doi:10.1089/cell.2009.0077 · Cited by 104
“However, the efficiency of generating human iPS cells with the transcription factor quartet (OCT3 = 4, SOX2, KLF4, and c-MYC) has been very low (Mali et al., 2008).”
From fibroblasts to iPS cells: Induced pluripotency by defined factors
Zhao, R., & Daley, G. Q. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21871 · Cited by 106
“Recently, a growing number of groups have succeeded in deriving human iPS cells, proving that the technique is robust [Lowry et al., 2008; Mali et al., 2008; Masaki et al., 2008].”
BackgroundShah, S. N., Kerr, C. L., Cope, L., Zambidis, E. T., Liu, C., Hillion, J., Belton, A., Huso, D. L., & Resar, L. M. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048533 · Cited by 110
“) platform to analyze bisulfate-treated DNA (EX DNA Methylation kit, Zymo Research) containing 27,578 informative sites near promoter regions as previously described [10].”
BackgroundActivation of Pluripotency Genes in Human Fibroblast Cells by a Novel mRNA Based Approach
Plews, J. R., Li, J., Jones, M., Moore, H. D., Mason, C., Andrews, P. W., & Na, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014397 · Cited by 101
“chosen because it has been shown to improve the efficiency and pace of reprogramming[2,18], although it may also increase the risk of tumorigenecity due to its ability to inhibit p53 function [19,20,21,22,23,24,25].”
Abaci, H. E., Truitt, R., Luong, E., Drazer, G., & Gerecht, S. (2010) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00484.2009 · Cited by 101
Brouwer, M., Zhou, H., & Nadif Kasri, N. (2016) · Stem Cell Reviews and Reports · doi:10.1007/s12015-015-9622-8 · Cited by 95
“SV40 large T antigen inhibits p53 tumor suppression apoptosis/cell cycle + [54, 61]”
BackgroundSchnerch, A., Cerdan, C., & Bhatia, M. (2010) · Stem Cells · doi:10.1002/stem.298 · Cited by 92
Chou, B.-K., Gu, H., Gao, Y., Dowey, S. N., Wang, Y., Shi, J., Li, Y., Ye, Z., Cheng, T., & Cheng, L. (2015) · Stem Cells Translational Medicine · doi:10.5966/sctm.2014-0214 · Cited by 91
Self-citationMedvedev, S. P., Grigor’eva, E. V., Shevchenko, A. I., Malakhova, A. A., Dementyeva, E. V., Shilov, A. A., Pokushalov, E. A., Zaidman, A. M., Aleksandrova, M. A., Plotnikov, E. Y., et al. (2010) · Stem Cells and Development · doi:10.1089/scd.2010.0249 · Cited by 94
“Use of the mouse genes for human cell reprogramming is quite reasonable, because the nucleotide sequences of Oct4, Sox2, Klf4, and c-Myc, as well as the amino acid sequences of the encoded proteins, are highly conserved [29,30].”
Induced pluripotent stem cells for modelling human diseases
Unternaehrer, J. J., & Daley, G. Q. (2011) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2011.0017 · Cited by 80
A Transcriptional Roadmap to the Induction of Pluripotency in Somatic Cells
Wang, Y., Mah, N., Prigione, A., Wolfrum, K., Andrade-Navarro, M. A., & Adjaye, J. (2010) · Stem Cell Reviews and Reports · doi:10.1007/s12015-010-9137-2 · Cited by 82
“supplemented the six reprogramming factors (OCT4, SOX2, KLF4, c-MYC, NANOG, and LIN28) with SV40 large T antigen to increase the efficiency of reprogramming of human fetal and adult fibroblasts to iPS cells by 23-70fold [25].”
BackgroundInduced pluripotent stem cells: A new era for hepatology
Asgari, S., Pournasr, B., Salekdeh, G. H., Ghodsizadeh, A., Ott, M., & Baharvand, H. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.05.009 · Cited by 79
“These include the application of various sets of reprogramming factors [70,77], reprogramming different somatic cell types [2,31,140], application of chemicals/small molecules to increase efficiency, replacing reprogramming factors [51,88,114], and the use of hypoxia conditions [65].”
BackgroundMiR-25 Regulates Wwp2 and Fbxw7 and Promotes Reprogramming of Mouse Fibroblast Cells to iPSCs
Lu, D., Davis, M. P. A., Abreu‐Goodger, C., Wang, W., Campos, L. S., Siede, J., Vigorito, E., Skarnes, W. C., Dunham, I., Enright, A. J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040938 · Cited by 78
Trokovic, R., Weltner, J., Noisa, P., Raivio, T., & Otonkoski, T. (2015) · Stem Cell Research · doi:10.1016/j.scr.2015.06.001 · Cited by 83
“Our results are in line with previous findings showing that cellular senescence negatively correlates with reprogramming efficiency (Banito et al., 2009; Mali et al., 2008; Qin et al., 2007; Zhao and Daley, 2008; Zhao et al., 2008).”
Cancer-Related Epigenome Changes Associated with Reprogramming to Induced Pluripotent Stem Cells
Ohm, J. E., Mali, P., Van Neste, L., Berman, D. M., Liang, L., Pandiyan, K., Briggs, K. J., Zhang, W., Argani, P., Simons, B., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1361 · Cited by 73
Self-citationCell replacement therapy for Parkinson's disease
Wijeyekoon, R., & Barker, R. A. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.10.007 · Cited by 80
“apoptotic activity, has also been demonstrated by Mali et al (23-70 fold increase in reprogramming) [217].”
The emerging role of p53 in stem cells
Bonizzi, G., Cicalese, A., Insinga, A., & Pelicci, P. G. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.08.002 · Cited by 78
Generation of hircine-induced pluripotent stem cells by somatic cell reprogramming
Ren, J., Pak, Y., He, L., Qian, L., Gu, Y., Li, H., Rao, L., Liao, J., Cui, C., Xu, X., et al. (2011) · Cell Research · doi:10.1038/cr.2011.37 · Cited by 70
Non-Integrating Lentiviral Vectors in Clinical Applications: A Glance Through
Gurumoorthy, N., Nordin, F., Tye, G. J., Wan Kamarul Zaman, W. S., & Ng, M. H. (2022) · Biomedicines · doi:10.3390/biomedicines10010107 · Cited by 69
Wen, W., Zhang, J.-P., Xu, J., Su, R. J., Neises, A., Ji, G.-Z., Yuan, W., Cheng, T., & Zhang, X.-B. (2016) · Stem Cell Reports · doi:10.1016/j.stemcr.2016.04.005 · Cited by 67
“…retroviral vectors expressing Yamanaka factors (OCT4, SOX2, KLF4, and MYC) has been found to be successful Stem This is an open access arti in many cell types, including hematopoietic cells (Aasen et al., 2008; Broxmeyer et al., 2011; Loh et al., 2009; Mali et al., 2008, 2010; Park et al., 2008).”
BackgroundLiu, Y., Wang, Y., Gao, Y., Forbes, J. A., Qayyum, R., Becker, L. C., Cheng, L., & Wang, Z. Z. (2015) · Stem Cells Translational Medicine · doi:10.5966/sctm.2014-0183 · Cited by 70
Self-citationJin, Z., Okamoto, S., Mandai, M., & Takahashi, M. (2009) · Journal of Genetics · doi:10.1007/s12041-009-0063-5 · Cited by 67
“Recently, several groups have reported improved efficiency in generating human iPS cells with the supplementation of some additional factors including valproic acid (histone deacetylase inhibitor) and the SV40 large T antigen (Huangfu et al. 2008; Mali et al. 2008).”
BackgroundInduced pluripotent stem (iPS) cells as in vitro models of human neurogenetic disorders
Chamberlain, S. J., Li, X.-J., & Lalande, M. (2008) · Neurogenetics · doi:10.1007/s10048-008-0147-z · Cited by 73
“The expression of the mRNAs is then measured for lineage-specific markers of the three germ layers; GATA binding protein 4 (GATA4) and alpha-fetoprotein for mesoderm; msh homeobox 1 and T (Brachyury mouse homolog) for mesoderm; and NES (nestin) and paired box 6 (PAX6) for ectoderm.”
BackgroundEmbryonic Stem Cells or Induced Pluripotent Stem Cells? A DNA Integrity Perspective
Baï, Q., Desprat, R., Klein, B., Lemaître, J.-M., & Vos, J. D. (2013) · Current Gene Therapy · doi:10.2174/1566523211313020003 · Cited by 70
Multisystem Lewy body disease and the other parkinsonian disorders
Langston, J. W., Schüle, B., Rees, L., Nichols, R. J., & Barlow, C. (2015) · Nature Genetics · doi:10.1038/ng.3454 · Cited by 63
Deng, Y., Liu, Q., Luo, C., Chen, S., Li, X., Wang, C., Liu, Z., Lei, X., Zhang, H., Sun, H., et al. (2012) · Stem Cells and Development · doi:10.1089/scd.2012.0018 · Cited by 69
“It had been reported that SV40 large T antigen combined with other iPSCs-related factors could improve the reprogramming of human iPSCs [36].”
Design and potential of non-integrating lentiviral vectors
Shaw, A., & Cornetta, K. (2014) · Biomedicines · doi:10.3390/biomedicines2010014 · Cited by 60
“Transgene free iPS cells have been produced using integrating LV followed by excision with NILVs after reprogramming [123] as well as by transient expression using both non-integrating adenoviral vectors [142,143] and NILV [122].”
BackgroundMethodRegulatory Issues for Personalized Pluripotent Cells
Condic, M. L., & Rao, M. S. (2008) · Stem Cells · doi:10.1634/stemcells.2008-0421 · Cited by 61
The Molecular Mechanism of Induced Pluripotency: A Two-Stage Switch
Scheper, W., & Copray, S. C. V. M. (2009) · Stem Cell Reviews and Reports · doi:10.1007/s12015-009-9077-x · Cited by 67
“For example, partially reprogrammed cells are commonly observed to be rather heterogeneous in features such as global expression profile and morphology [5, 6, 11].”
BackgroundResultCollin, J., & Lako, M. (2011) · Stem Cells · doi:10.1002/stem.658 · Cited by 62
Gene-delivery systems for iPS cell generation
Shao, L., & Wu, W.-S. (2010) · Expert Opinion on Biological Therapy · doi:10.1517/14712590903455989 · Cited by 71
The old and the new: Prospects for non-integrating lentiviral vector technology
Apolonia, L. (2020) · Viruses · doi:10.3390/v12101103 · Cited by 58
“It was found that, although NILVs were able to generate iPS cells, the efficiency was ~50-fold lower compared to their integrating counterparts, and that regardless of the vector system used, all generated clones had an integrated copy of the SV40 large T antigen gene (most likely arising from illegitimate integration…”
ResultGenomic instability in iPS: time for a break
Blasco, M. A., Serrano, M., & Fernández-Capetillo, Ó. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.50 · Cited by 59
“In addition, reprogramming can also be stimulated by the presence of other oncogenes such as SV40 large T antigen (Mali et al, 2008) or by the loss of tumour suppressors like p53 or Arf (Menendez et al, 2010).”
BackgroundPelascini, L. P. L., Janssen, J. M., & Gonçalves, M. A. F. V. (2013) · Human Gene Therapy · doi:10.1089/hum.2012.069 · Cited by 57
“IDLVs have also been tested for the ex vivo delivery of transcription factors to reprogram somatic cells into induced pluripotent stem cells (Mali et al., 2008).”
BackgroundKantor, B., Bayer, M., Ma, H., Samulski, J., Li, C., McCown, T., & Kafri, T. (2011) · Molecular Therapy · doi:10.1038/mt.2010.277 · Cited by 56
Zhang, Y., Wei, C., Zhang, P., Li, X., Liu, T., Pu, Y., Li, Y., Cao, Z., Cao, H., Liu, Y., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085089 · Cited by 56
Ovine-Induced Pluripotent Stem Cells Can Contribute to Chimeric Lambs
Sartori, C., Domenico, A. I. D., Thomson, A. J., Milne, E., Lillico, S. G., Burdon, T., & Whitelaw, B. (2012) · Cellular Reprogramming · doi:10.1089/cell.2011.0050 · Cited by 55
Khatau, S. B., Kusuma, S., Hanjaya‐Putra, D., Mali, P., Cheng, L., Lee, J. S. H., Gerecht, S., & Wirtz, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036689 · Cited by 55
“Linzhao Cheng [25]) were grown on an inactivated mouse embryonic feeder layer (Globalstem, Rockville, MD) in growth medium consisting of 80% ES-DMEM/F12”
BackgroundMethodInfluentialSelf-citationp53 orchestrates between normal differentiation and cancer
Rivlin, N., Koifman, G., & Rotter, V. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.12.006 · Cited by 62
Serial imaging of human embryonic stem-cell engraftment and teratoma formation in live mouse models
Pomper, M. G., Hammond, H., Yu, X., Ye, Z., Foss, C. A., Lin, D. D. M., Fox, J. J., & Cheng, L. (2008) · Cell Research · doi:10.1038/cr.2008.329 · Cited by 52
Self-citationReprogramming human fibroblasts using HIV-1 TAT recombinant proteins OCT4, SOX2, KLF4 and c-MYC
Pan, C., Lu, B., Chen, H., & Bishop, C. E. (2009) · Molecular Biology Reports · doi:10.1007/s11033-009-9680-6 · Cited by 48
“[6] show that the use of the SV40 large T antigen (T) increases efficiency 23–70 fold when C.”
BackgroundSchaefer, T., Steiner, R., & Lengerke, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144902 · Cited by 55
The Epigenetic Reprogramming Roadmap in Generation of iPSCs from Somatic Cells
Brix, J., Zhou, Y., & Luo, Y. (2015) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2015.10.001 · Cited by 55
RNA: state memory and mediator of cellular phenotype
Kim, J., & Eberwine, J. H. (2010) · Trends in Cell Biology · doi:10.1016/j.tcb.2010.03.003 · Cited by 53
Applications of 3D Bioprinting Technology in Induced Pluripotent Stem Cells-Based Tissue Engineering
Shukla, A. K., Gao, G., & Kim, B. S. (2022) · Micromachines · doi:10.3390/mi13020155 · Cited by 49
“SV40 LT (T) SV40 large T antigen used for cell transformation Klf4; N-Myc and Lin28, Nanog [27]”
BackgroundConcise Review: Human Cell Engineering: Cellular Reprogramming and Genome Editing
Mali, P., & Cheng, L. (2011) · Stem Cells · doi:10.1002/stem.735 · Cited by 48
“four broad categories (Figure 1D, Table): first, factors that promote cell immortalization, proliferation and improvement of survival potential of cells, such as SV40 Large T antigen, hTERT and reagents that reduce p53 levels [15,16]; second, modulation of the underlying epigenetic state of the cells to promote active…”
BackgroundSelf-citationGeneration of male differentiated germ cells from various types of stem cells
Hou, J., Yang, S., Yang, H., Liu, Y., Liu, Y., Hai, Y., Chen, Z., Guo, Y., Gong, Y., Gao, W., et al. (2014) · Reproduction · doi:10.1530/rep-13-0649 · Cited by 48
“…cells: the use of oncogenic factors or vectors in inducing the pluripotency of iPS cells may cause tumorigenesis, since the reprogramming of somatic cells to iPS cells requires an oncogenic factor to achieve a higher transfection efficiency (Aasen et al. 2008, Mali et al. 2008, Yu & Thomson 2008).”
BackgroundZhang, Z., Gao, Y., Gordon, A., Wang, Z. Z., Qian, Z., & Wu, W.-S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026592 · Cited by 51
“01% [30,31].”
Lei, Y., Lee, C.-L., Joo, K.-I., Zarzar, J., Liu, Y., Dai, B., Fox, V., & Wang, P. (2011) · Molecular Therapy · doi:10.1038/mt.2011.12 · Cited by 42
Patient-Specific Pluripotent Stem Cells in Neurological Diseases
Durnaoglu, S., Genç, Ş., & Genç, K. (2011) · Stem Cells International · doi:10.4061/2011/212487 · Cited by 47
“The differentiation of human iPSCs including patient-specific iPSCs into neural ectoderm cells [82] has been demonstrated by positive staining for NES [83], increased expression of PAX6, and neural cell adhesion molecule mRNAs [31, 84].”
BackgroundCurrent Applications of Human Pluripotent Stem Cells: Possibilities and Challenges
Ho, P.-J., Yen, M., Yet, S., & Yen, B. L. (2012) · Cell Transplantation · doi:10.3727/096368911x627507 · Cited by 49
Qin, D., Gan, Y., Shao, K., Wang, H., Li, W., Wang, T., He, W., Xu, J., Zhang, Y., Kou, Z., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m806788200 · Cited by 41
Kumar, P., & Chan, W. (2011) · Current Gene Therapy · doi:10.2174/156652311794940782 · Cited by 44
“recently demonstrated generation of iPSC with enhanced efficiency using IDLVs [97].”
Advancements in reprogramming strategies for the generation of induced pluripotent stem cells
Lai, M. I., Wendy-Yeo, W. Y., Ramasamy, R., Nordin, N., Rosli, R., Veerakumarasivam, A., & Abdullah, S. (2011) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-011-9552-6 · Cited by 48
“The presence of c-Myc as one of the transcription factors involved in reprogramming has been linked to carcinogenesis and reactivation of this gene will have cancer-causing potential in iPS cells [6, 9, 11].”
BackgroundWada, H., Kojo, S., Kusama, C., Okamoto, N., Sato, Y., Ishizuka, B., & Seino, K. (2010) · International Immunology · doi:10.1093/intimm/dxq458 · Cited by 43
Induced Pluripotent Stem Cells: Emerging Techniques for Nuclear Reprogramming
Han, J. W., & Yoon, Y. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3814 · Cited by 50
“OK Dermal papilla cells (179) OK NSCs (54) OK/O NSCs (71) Lentiviral vectors OSKM/OSNL Fibroblasts Large T (104) OSNL Fibroblasts from patients (33) OSNL Cord blood cells (47) Inducible lentiviral vectors (tet) OSKM/OKM/OSK Melanocytes (181) OSKM Blood cell, T cell/PB–MNC (96) Inducible lentiviral vectors (tet), singl…”
BackgroundDaniels, B. R., Hale, C. M., Khatau, S. B., Kusuma, S., Dobrowsky, T. M., Gerecht, S., & Wirtz, D. (2010) · Biophysical Journal · doi:10.1016/j.bpj.2010.10.007 · Cited by 39
“org/biophysj/supplemental/ S0006-3495(10)01255-5.”
BackgroundMethodInfluentialHo, P.-J., Yen, M., Lin, J.-D., Chen, L., Hu, H.-I., Yeh, C.-K., Peng, C.-Y., Lin, C., Yet, S., & Yen, B. L. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.206540 · Cited by 41
Self-citationSaliba, J., Hamidi, S., Lenglet, G., Langlois, T., Yin, J., Cabagnols, X., Secardin, L., Legrand, C., Galy, A. H. M., Opolon, P., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074257 · Cited by 44
“fibroblasts (MEF) in ES medium [39].”
Induced pluripotent stem cell-based therapy for age-related macular degeneration
Bracha, P., Moore, N. A., & Ciulla, T. A. (2017) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2017.1346079 · Cited by 42
“have developed methods for improving the efficiency of pluripotency induction through the use of factors such as valproic acid [57], SV40 large T antigen [58], and microRNA [59].”
MethodNaked Mole Rat Induced Pluripotent Stem Cells and Their Contribution to Interspecific Chimera
Lee, S.-G., Mikhalchenko, A. E., Yim, S. H., Lobanov, A. V., Park, J.-K., Choi, K.-H., Bronson, R. T., Lee, C.-K., Park, T. J., & Gladyshev, V. N. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.09.013 · Cited by 37
“Reducing p53 expression can also improve this process (Mali et al., 2008; Utikal et al., 2009; Hong et al., 2009; Hanna et al., 2009a).”
BackgroundMorales Pantoja, I. E., Smith, M. D., Rajbhandari, L., Cheng, L., Gao, Y., Mahairaki, V., Venkatesan, A., Calabresi, P. A., Fitzgerald, K. C., & Whartenby, K. A. (2020) · PLOS ONE · doi:10.1371/journal.pone.0233980 · Cited by 37
Self-citationThe Use of Induced Pluripotent Stem Cells for the Study and Treatment of Liver Diseases
Hansel, M. C., Davila, J. C., Vosough, M., Gramignoli, R., Skvorak, K. J., Dorko, K., Marongiu, F., Blake, W. L., & Strom, S. C. (2016) · Current Protocols in Toxicology · doi:10.1002/0471140856.tx1413s67 · Cited by 43
“The lack of a comprehensive database, nomenclature, or minimum information standards has led to confusion and ineffectiveness in collecting and sharing information across the scientific community (Martell et al., 2010; Luong et al., 2011; Lowenthal et al., 2012).”
Background
Metadata
- Authors
- Mali, P., Ye, Z., Hommond, H. H., Yu, X., Lin, J., Chen, G., Zou, J., & Cheng, L.
- Affiliations
- Johns Hopkins University (US)
- Corresponding author
- Cheng, Linzhao
- Venue
- Stem Cells
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-05-29
- Volume
- 26
- Issue
- 8
- Pages
- 1998-2005
- ISSN
- 1066-5099 (ISSN-L)
- 1549-4918
- OpenAlex
- W2061824613
- Cited by
- 291
- References
- 32
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 3 · 2023: 4 · 2022: 9 · 2021: 9 · 2020: 9 · 2019: 7 · 2018: 8 · 2017: 9 · 2016: 14 · 2015: 19 · 2014: 19 · 2013: 20 · 2012: 30
- FWCI
- 17.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Stem Cells (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01hl073781-10)
- National Heart, Lung, and Blood Institute (R01 HL-073781)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Animal Genetics and Reproduction
- Keywords
- induced pluripotent stem cells, fibroblast reprogramming, SV40 large T antigen, reprogramming efficiency, human embryonic stem cells, teratoma formation, embryoid body differentiation, trophoblast differentiation, sickle cell disease, stem cell markers
- MeSH terms
- Animals, Antigens, Polyomavirus Transforming, Cell Differentiation, Cell Line, Culture Media, Fibroblasts, Homozygote, Humans, Karyotyping, Mutation, Lentivirus, Transgenes, Pluripotent Stem Cells, Embryo Culture Techniques, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.